Which Metastatic Breast Cancer Treatment Is Right for You? What You Need to Know

What do you need to know before deciding which treatment is best for YOUR metastatic breast cancer? Expert Dr. Jane Meisel reviews recent research news, discusses the role of key tests--including biomarker testing --in determining a treatment plan, and shares advice for self-advocacy.
Jane Lowe Meisel, MD is an Associate Professor of Hematology and Medical Oncology at Winship Cancer Institute at Emory University. Learn more about Dr. Meisel.
[Editor’s Note: On August 23, 2021, the U.S. Food and Drug Administration (FDA) approved the Pfizer-BioNTech COVID-19 Vaccine for individuals 16 years of age and older.]
Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome. Subscribe now to receive the latest news on cancer treatment and research: powerfulpatients.org/connect

[@maver1706]

Very informative and interesting thank you. It would have been good to know what the next course of treatment could be after taking the 3 targeted therapies Ribociclib, Abemaciclib and Alpelisib and there has been progression after each treatment. (In oestrogen receptive metastatic b/c)

[@daitchieboyd6114]

Please help me...Drs will not see me unless I do chemo...please help me my cancer has spread...to bones and liver

[@elissajury4464]

Thank you

[@aremedyproject9569]

Great talk. Thank you!

[@catherineadofina3471]

5